Back to Products
Tablet
MONEAST-B
BILASTINE(20MG), MONTELUKAST SODIUM eq. to MONTELUKAST(10MG)
Empower your clinical outcomes with MONEAST-B, containing BILASTINE(20MG), MONTELUKAST SODIUM eq. to MONTELUKAST(10MG), manufactured under strict WHO-GMP compliance by Ramitra Biotech in 10 x 10 Aluminium packing to ensure maximum purity and bioavailability.
📋 Specifications
| Product Name | MONEAST-B |
|---|---|
| Composition | BILASTINE(20MG), MONTELUKAST SODIUM eq. to MONTELUKAST(10MG) |
| Category | Tablet |
| Packaging | 10 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
MONEAST-B is a advanced, dual-action capsule designed for comprehensive management of allergic conditions.
Each capsule delivers 20mg of Bilastine, a highly selective, non-sedating H1-antihistamine that provides rapid and effective relief from allergic symptoms.
Complementing this is Montelukast Sodium equivalent to 10mg of Montelukast, a leukotriene receptor antagonist that reduces inflammation and helps control symptoms associated with allergic rhinitis and asthma prophylaxis.
This synergistic formulation targets both histamine and leukotriene pathways, offering enhanced efficacy in controlling complex allergic reactions and related respiratory symptoms.
Engineered as a convenient capsule, MONEAST-B supports improved patient adherence for consistent and sustained symptom relief.
Indicated for the symptomatic treatment of allergic rhinoconjunctivitis, chronic urticaria, and as an adjunct in asthma management where concomitant allergic rhinitis is present.
Quantity
